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Introduction
The “International Classification of Disease” characteri-
zes maternal death as “death of a woman while pregnant or 
within 42 days of termination of pregnancy from any cause 
related or aggravated by the pregnancy or its management, 
but not from accidental or incidental causes”(1) and sets forth 
the concept of pregnancy-related death, i.e. the death of a 
woman while pregnant or within 42 days of termination of 
pregnancy regardless of the cause of death. Maternal death 
can be traced back to clinical, care-related and organizatio-
nal factors, e.g. a failure to communicate between medical 
and paramedical personnel, unavailability of one or more 
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specialists for counseling, lack of hospital beds in intensive 
care units or the availability of intensive care in a hospital 
too far away, lack of blood or derivatives, etc…(2). 
Furthermore, it is noteworthy that a more frequent use 
of caesarean sections in Italy (37% of births in 2003, 38% 
in 2004) than European average and in particular Anglo-
Saxon countries (23% in 2003-2004) may enhance the risk 
of exposure to maternal morbidity and mortality for some 
clinical conditions (e.g. thromboembolic syndrome and 
anesthesia-related death) (3). 
The study is meant to analyze the difficulties associated 
with an AFE diagnosis
AFE calls for a complex and articulate approach on the 
part of forensic pathologists, who need to identify the cause 
of death and afterwards, once the physiopathological me-
chanisms leading to maternal death have been established, 
ascertain whether there have occurred inappropriate proce-
dures or mistakes during the pregnancy, labor or delivery 
management (4)
Diagnosis of AFE
Amniotic fluid embolism is still a diagnosis of exclusion, 
although the scientific kknowledge in this field is increasing. 
In fact, according to Thongrong (5) amniotic fluid embolism 
has likely occurred when, during labor, delivery or within 
30 minutes of delivery one or more of the following events 
takes place:
acute hypotension
cardiac arrest
acute hypoxemia or respiratory distress
severe hemorrhage or coagulopathy
 
Nonetheless, such data have not been scientifically but-
tressed. In fact, in scientific literature one instance of AFE 
has been reported occurring two hours after natural delivery 
(6) and, according to Fineschi et all., AFE can occur as late 
as 48 hours after delivery (7).
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The initial signs and symptoms which may lead one to 
suspect an AFE instance are non-specific. They include:
abrupt cardiac and respiratory failure
dyspnea
altered consciousness
restlessness
Cyanosis
seizures and uterine atony 
Such a pathology still entails significant morbidity and 
mortality rates and permanent brain damage for those pa-
tients who survive.
Presently, numerous aspects involving the pathophysio-
logy and clinical development are still not understood and 
several hypotheses have been formulated, in particular a 
possible role of anaphylaxis and the role of the complement 
in the onset of adult respiratory distress as a consequence 
of AFE (8 ,9).
Thus, only an autopsy can confirm with a high degree 
of certitude an AFE diagnosis (5).
It is extremely hard to diagnose AFE, therefore physi-
cians need to comply with proper methodology to decrease 
the margin of error as much as possible.
Thus, according to Rudra et a., (10) a set of valuable 
diagnostic tools are available: 
– electrocardiogram and pulse oximetry to continuously monitor 
the oxygen saturation;
– chest X-ray to control right atrium and ventricle, pulmonary 
artery and pulmonary edema;
– electrocardiogram and pulse oximetry to continuously monitor 
the oxygen saturation;
– chest X-ray to control right atrium and ventricle, pulmonary 
artery and pulmonary edema;
– central venous pressure, which can be risen by the pulmo-
nary hypertension but drops very much in case of severe 
hemorrhage;
– coagulation profile, because disseminated intravascular coa-
gulation is often associated with AFE
Nevertheless, unlike what was believed in the past, the 
mere presence of amniotic fluid material in the bloodstream 
does not prove an AFE instance, because such a reaction does 
not stem from the presence of amniotic fluid, but only from 
some components of its (7). Hence, a differential diagnosis 
is of the utmost importance.
In fact, as affirmed by Rudra et al., (10) cardiopulmonary 
collapse and severe hemmorrage may be caused not only by 
AFE but also by the following conditions:
– thrombotic pulmonary embolism
– air embolism;
– eclamptic convulsions and coma; Convulsion from toxic reac-
tion to local anaesthetic drugs;
– acute left heart failure;
– cerebrovascular accident;
– aspiration of gastric contents into the lungs;
– hemorrhagic shock
Since AFE can cause the deaths of the mother and the 
fetus within few hours, it is vital that the gynecologist 
knows from the very beginning what circumstances, signs 
and symptoms to take into account upon formulating such 
differential diagnosis. 
Treatment
While facing cardiac arrest, it is necessary to place the 
parturient in left lateral decubitus position because the ob-
struction of the inferior vena cava due to the late pregnancy 
limits the venous return and compromises the cardio pul-
morary resuscitation.
If these attempts were useless, the caesarean delivery of 
the foetus would become necessary in order to increase the 
chances of maternal and neonatal survival (6,10,11,12,13). 
The American Society of Anesthesiologists Task Force 
on Obstetric Anesthesia recommends to perform the peri-
mortem cesarean delivery within five minutes (14). 
According to Einav et al. (15), such a timeframe is 
unrealistic and risky because it may produce a pessimistic 
attitude when the medical staff cannot meet that standard. 
Consequently, delivery should be performed within 10 min 
of arrest. 
Besides, proper clinical procedures require the hardest 
effort in sustaining vital functions.
According to Thongrong et al.,(5) doctors should stick 
to the following pattern.
In order to address the airway and respiratory conditions, 
high flow oxygen must be immediately administered. High 
frequency oscillatory ventilation or extracorporeal mem-
brane oxygenation (ECMO) may be necessary. Doctors 
should also be ready to use of a fiberoptic scope or even 
tracheotomy. 
With regard to hypotension and maternal circulation, they 
suggest establishing a central venous access and utilizing a 
urinary catheter because these tools help with guiding the 
administration of the therapies (15). The treatment should 
comprise: 
– blood products to treat hemorrhage: the choice of the 
products to be administered depends on the laboratory stu-
dies; as last chance could be used recombinant activated 
factor VII;
– isotonic solution because it is useful to maximize preload;
– vasopressors and inotropes to oppose refractory hypotension;
– inotropic support to treat ventricular contractile impairment;
– milrinone because it supports the right heart support impro-
ving both inotropy and pulmonary vasculature;
– inhaled nitric oxide or inhaled epoprostenol to treat refractory 
hypoxemia and to unload the right ventricle;
– as last options, intraaortic balloon pump, right ventricular 
assist device and/or ECMO
According to Shah et al. (16), a pulmonary artery cath-
eter should be placed before analgesia in order to early 
diagnose pulmonary hypertension and to establish a favour-
able hemodynamic management. Stanten et al. (17) report 
the case of a 45 year old woman with placenta previa who 
developed AFE during cesarean delivery. The transesopha-
geal echocardiogram examination showed catastrophic 
pulmonary vasoconstriction that was successfully treated 
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by cardiopulmonary bypass, heparin, epinephrine, and high-
dose steroids. In another case report of AFE with postpartum 
hemorrhage and coagulopathy due to disseminated intravas-
cular coagulation, the physicians used administrated 100% 
oxygen, noradrenaline and blood transfusion and performed 
uterine artery embolization. So, they managed to stop PPH 
and DIC within seven hours and both the woman and the 
baby had no complications (18). 
Nagarsheth recounts a case in which nitric oxide pro-
duced no effect and medical staff obtained the resuscita-
tion of a woman with probable AFE by placing a Right 
Ventricular Assist Device to treat severe pulmonary arterial 
hypertension and by using recombinant factor VIIa to oppose 
massive hemorrhage (19). 
Medico-legal discussion
AFE arises from the entry of amniotic fluid into the ma-
ternal circulation. In fact, it usually occurs during labor and 
delivery or in the postpartum period, but it can also happen 
with amniocentesis, abortion, abdominal trauma, removal 
of placenta, cervical suture removal and ruptured uterus or 
intrapartum amnioinfusion (6) 
Consequently, it is necessary to avoid every unnecessary 
trauma to the uterus. Moreover, it is useful to administer 
intravenous β-adrenergic drugs or magnesium sulphate in 
order to control excessively intense and recurring uterine 
contractions, because tumultuous labor is considered a 
risk 
Scientific research (20) has identified the following risk 
factors which may lay the groundwork for AFE to occur:
a) maternal age ≥35 years; 
b) multiple pregnancies;
c) placenta previa and placental abruption; 
d) eclampsia; 
e) induction of labor; 
f) Caesarean section
Yet, a survey by Fineschi et al. (6) have stressed that the 
above--mentioned factors were absent in at least half cases, 
and that initial clinical signals were extremely varied.
As a consequence, even when the known risk factors are 
missing in real cases, doctors need to pay high attention and 
be ready to apply all proper resuscitation techniques at the 
slightest suspicious sign.
In fact, by the current state of scientific knowledge and 
despite the commitment of many a researcher, doctors have 
still few references when dealing with an AFE case, and there 
are no precautionary measures to prevent its occurrence.
Therefore, any judgment as to the liability must be 
centered on the quality and speed of any diagnostic and 
therapeutic response when facing a potential AFE case. 
(2,21) Not all of the above-reported therapies are so widely 
validated as to be deemed standard care procedures.
In fact, according to Rudra et al., (10) newer methods 
such as intra aortic balloon counterpulsation, extracorporeal 
membrane oxygenation, cardiopulmonary bypass, plasma 
exchange transfusion, Uterine artery embolization, inhaled 
nitric oxide (22), cell-salvage combined with blood filtration, 
serum protease inhibitors, inhaled prostacyclin and high 
dose corticosteroids (23) are based on not very significant 
case reports (6). 
Consequently, the omission of such strategies cannot be 
considered as a failure to meet the standard of care.
Medical liability in AFE cases
In case of damage, in order to file suit three requirements 
need to be met: the accidental nature of the misconduct 
on the part of hospital personnel, the existence of proven 
damage and a causal relationship. Doctors need to put in 
place all necessary measures according to current scientific 
knowledge. They must encompass not just the treatment, but 
the diagnosis as well, all activities prior to the procedure and 
post-operatory stages.
In legal frameworks such as the Italian one, according to 
which the burden of proof rests on healthcare facilities, the 
institutions are called upon to prove that proper, qualified 
medical personnel and safe equipment was available. Thus, 
they must prove that the harmful outcome was brought about 
by an unforeseeable event (24). Otherwise, the court is bound 
to sentence them to redress the damage.
In a suit involving a patient who suffered permanent 
damages in the aftermath of a hysterectomy, the Courthouse 
of Cassino has sentenced both the doctor and the hospital 
to damage compensation. The judges in the case have 
acknowledged that AFE is hard to diagnose with certainty. 
Consequently, the court has convicted them on account 
of their failure to provide proper care and because of the 
seriously delayed resuscitation procedures.
 “According to the judge, in fact, the substandard care 
was identified in the severe delay of resuscitation activities. 
The ob-gyn was held responsible for having waited for 
the anaesthetist, without providing the first aid (external 
cardiac massage, artificial respiration and administration 
of oxygen) to the patient. Hospital instead was held liable 
for not providing a well-equipped delivery room: the results 
of inquiry showed the lack of oxygen, defibrillator and kit 
surgery” (25). 
In AFE cases, as mentioned before, caesarean sections 
are deemed to be a risk factor too. Thus, if the overall inci-
dence of caesarean sections decreased, so would probably 
the cases of AFE. Hence, it is necessary to take into account 
the hypothesis by which AFE may occur during or after a 
caesarean section carried out with no medical indication. 
Unless the patient deliberately refuses a natural delivery, 
a choice on the part of the doctor to perform a caesarean 
section without medical indication constitutes a breach of the 
standard of care, in that it exposes to a pointless risk and an 
otherwise avoidable surgery. Nevertheless, it appears to be 
hard to prove that, had a caesarean section not been carried 
out, (more likely than not), the AFE occurrence would not 
have happened.
As far as the causal relationship is concerned, available 
data on prognosis and outcomes are contradictory. In fact, the 
mortality rate ranges from 20% to 40% and most survived 
patients suffers permanent damages, whereas only 20%-25% 
of infants perishes and 50% of survivors reports no disabi-
lity whatsoever(5). Other studies maternal mortality rates 
between 27% to 37% (26, 27). Totally conflicting data are 
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provided by Kainer et al.: maternal mortality ranges from 
60% to 80% (28).
Anyway, according to both Italian Law and Common 
Law, the causal relationship cannot be proven based solely 
on statistical data; on the contrary, it is necessary to take 
into account all circumstances as to each individual case 
(Cassazione penale, sez. IV, 20 marzo 2012, n. 10864)
The very lack of scientific knowledge makes it harder to 
prove a causal relationship in AFE cases. In fact, no evidence 
exists as to the correlation between the gravity of an actual 
AFE case and the amount of amniotic fluid or its components 
found in a patient’s lungs (6).
However, a recent study argues that the maternal serum 
level of Sialyl Tn, which is tipically present in meconium, 
could be a prognostic factor able to identify fatal cases of 
AFE. In fact when amniotic fluid contains thick meconium 
it might be more toxic than the clear one. Consequently, the 
risk of neurological impairment or death is higher and car-
diac arrest occurs in a shorter time (29). If such an approach 
were confirmed, the amount of meconium could be applied 
as a standard to establish whether, provided that the proper 
therapy had been administered, the mother and/or the infant 
would have survived.
According to the Italian Supreme Court, even if it is not 
possible to prove that the medical error caused (more likely 
than not) the death or injury of the patient, the loss of chance 
to heal or survive is in itself a compensable damage. The 
criterion of the preponderance of evidence should be applied 
in establishing the causal connection between medical error 
and loss of chance.
Applying the above mentioned rule affirmed by the 
Supreme Court the ascertainment of the causation becomes 
superfluous.
The plaintiff complains only about the loss of possibili-
ties caused by the negligent conduct held by the doctor. If 
the loss of chance is a damage, the omission of the doctor 
and the actual existence of statistically significant chances 
of survival involve automatically the existence of a causal 
connection between the medical error and the damage (i.e. 
the loss of chance).
Conclusions
Based on what surfaces from this study, it is essential to 
further scientific knowledge of the causes of maternal death. 
In such a way, it will be possible to improve the quality 
standards of care and avert many pregnancy-related deaths. 
It is well-known how age of the mother also plays a role in 
determining the likelihood of developing AFE. The average 
age of pregnant women has increased over the past years. A 
substantial amount of research has shown that the percentage 
of women who get pregnant at 35 years of age or older rose 
from 9% in 1998 to 29% in 2007 (30).
This gives rise to serious issues for the healthcare system 
and women themselves. It is therefore important, following 
in the footsteps of France, the Netherlands and the United 
Kingdom, to set up a specific system of oversight on AFE-
related maternal deaths, in such a way as to rely on hard 
data in order to study all risk factors associated with the 
phenomenon with the purpose of providing patients with 
the best possible care.
All collected data will then be compared with those 
from other countries which already have such an oversight 
system in place, thus making possible the implementation 
of appropriate preventive measures to raise the quality 
standards of obstetric care. Furthermore, given that AFE is 
most serious and rare a complication, it would be necessary 
to be able to rely on multidisciplinary teams made up of 
obstetricians, anatomic pathologists, anesthetists, general 
practitioners, specialists in intensive care and emergency 
medicine and internists.  
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